The investigations were carried out on thyroids of white Wistar rats which were given Metizol for 3 days, 3 and 6 weeks at the dose of 1 mg/kg of b.m. for 24 hrs. The samples were stained with hematoxylin and eosin and by the PAS method. The following changes were observed: 1. Three-day administration of Metizol resulted in the decrease in the quantity of colloid; the secretory epithelium became uniform--i.e. cubic; the quantity of the interfollicular tissue increased. 2. Three-week administration of Metizol resulted in appearing of colloid stained differently than in the control group; secretory epithelium cells were of different height (cubic and cylindrical), a considerate congestion of the gland was visible, the quantity of the interfollicular tissue increased. 3. After 6 weeks of Metizol administration the morphological picture of the thyroid became similar to that of the control group.

Download full-text PDF

Source

Publication Analysis

Top Keywords

administration metizol
12
secretory epithelium
8
quantity interfollicular
8
interfollicular tissue
8
tissue increased
8
control group
8
metizol
5
histological examination
4
examination thyroid
4
thyroid experimental
4

Similar Publications

Background: Congenital hypothyroidism (CH) is a pathology that affects various organs, including the testicles. The mechanisms by which this condition alters fertility is unknown. This study aimed at determining if experimental CH affects gonocyte differentiation and arrests meiosis; and the possible role of the Sertoli cell (SC) in this condition.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to explore how Qixuan Yijianing (QYN) reduces heart damage in mice with Graves' disease (GD) through microRNA (miRNA) analysis.
  • After subjecting female BALB/c mice to GD modeling, they were treated with various doses of QYN and assessed for heart metrics and biochemical markers, revealing significant improvements in the high-dose QYN group.
  • The analysis found 151 differentially expressed miRNAs in the GD mice, with further changes in the miRNA profile post-treatment, suggesting that QYN may regulate heart functions through specific miRNAs involved in cardiac development.
View Article and Find Full Text PDF
Article Synopsis
  • Tracheobronchial mucormycosis is a serious and often fatal infection that leads to narrowing of the airways, making it hard to treat.
  • A case study involved a 37-year-old woman with a history of hyperthyroidism who developed severe airway issues after a medication caused her immune system to weaken.
  • Successful treatment included advanced therapies like venous-venous ECMO and prolonged use of antifungals, showing promising results in managing the infection.
View Article and Find Full Text PDF

The association between methimazole tapering and intractable Graves' disease in children.

Pediatr Int

October 2024

Department of Pediatrics, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea.

Background: The aim of this study was to find predictive factors for intractable Graves' disease (GD).

Methods: Ninety-three GD patients who visited two pediatric endocrinology clinics from March 2009 to August 2019 were involved in this study. Data were collected on the methimazole (MZ) dosages prescribed from their first visits to their fifth visits.

View Article and Find Full Text PDF

Introduction: The most common cause of hyperthyroidism, Graves' disease is a common organ-specific autoimmune disease. Selenium is an essential trace element of the human body that is mainly concentrated in the thyroid gland and is involved in the synthesis and metabolism of thyroid hormones. Most studies have shown that the level of selenium is closely related to the occurrence and development of thyroid diseases, and selenium supplementation can help improve thyroid function.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!